Oxaliplatin and capecitabine after gemcitabine failure in patients with advanced pancreatic, biliary, and gallbladder adenocarcinoma (APBC)
| Autor: | Guillermo Lopez-Vivanco, A. Moreno, N. Ancizar, J. Ferreiro, X. Mielgo, J. M. Mañé, Eluska Iruarrizaga, R. Fernández, I. Diaz de Corcuera, Aintzane Sancho |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty business.industry Gallbladder Standard treatment medicine.disease Gemcitabine Oxaliplatin Capecitabine medicine.anatomical_structure Internal medicine Gallbladder adenocarcinoma medicine Adenocarcinoma In patient sense organs business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 26:15625-15625 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2008.26.15_suppl.15625 |
| Popis: | 15625 Background: Patients (pts) with advanced pancreatic (P), biliary (B) and gallbladder (GB) adenocarcinoma have a poor prognosis. Gemcitabine (G) is the standard treatment for patients with APB... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|